Originally posted by the Voice of America.
Voice of America content is produced by the Voice of America,
a United States federal government-sponsored entity, and is in
the public domain.


Indian Company Says it Made Millions of Doses of AstraZeneca COVID-19 Vaccine
Candidate

Anjana Pasricha

   NEW DELHI - There is rising optimism in India about getting access to a
   prospective Covid 19 vaccine after Britain-based pharmaceutical company
   AstraZeneca announced this week that clinical trials of its vaccine
   candidate have shown that it is highly effective in preventing
   infections.

   An Indian vaccine manufacturing company, the Serum Institute of India,
   that has a licensing agreement with AstraZeneca to make the vaccine,
   has said it already has 40 million doses ready.

   WATCH:Anjana Pasricha's video report

.